Intuitive Surgical (NASDAQ:ISRG) Price Target Increased to $245.00 by Analysts at Mizuho

Intuitive Surgical (NASDAQ:ISRG – Get Rating) had its price target increased by Mizuho from $215.00 to $245.00 in a research note published on Tuesday morning, The Fly reports. The firm currently has a neutral rating on the medical equipment provider’s stock.

Several other equities research analysts have also weighed in on the stock. Barclays upped their target price on shares of Intuitive Surgical from $235.00 to $298.00 in a report on Wednesday, January 4th. Piper Sandler upped their target price on shares of Intuitive Surgical from $260.00 to $265.00 and gave the stock an overweight rating in a report on Wednesday, October 19th. Morgan Stanley upped their target price on shares of Intuitive Surgical from $235.00 to $290.00 and gave the stock an equal weight rating in a report on Friday, January 6th. Argus upped their target price on shares of Intuitive Surgical from $265.00 to $320.00 and gave the stock a buy rating in a report on Thursday, December 22nd. Finally, Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $262.00 to $305.00 and gave the stock an overweight rating in a report on Monday, December 12th. Seven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of Moderate Buy and a consensus target price of $280.53.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $257.98 on Tuesday. Intuitive Surgical has a 52-week low of $180.07 and a 52-week high of $308.97. The stock has a market cap of $91.17 billion, a price-to-earnings ratio of 68.07, a P/E/G ratio of 4.92 and a beta of 1.36. The firm has a fifty day moving average of $264.91 and a 200-day moving average of $234.18.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last announced its quarterly earnings data on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.25 by ($0.02). Intuitive Surgical had a net margin of 22.52% and a return on equity of 11.54%. The business had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.66 billion. During the same quarter in the prior year, the company posted $1.30 EPS. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, sell-side analysts predict that Intuitive Surgical will post 3.77 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 8,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 1st. The shares were sold at an average price of $250.06, for a total transaction of $2,000,480.00. Following the sale, the executive vice president now directly owns 217 shares in the company, valued at approximately $54,263.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the firm’s stock in a transaction that occurred on Tuesday, November 8th. The shares were sold at an average price of $239.36, for a total transaction of $1,525,920.00. Following the sale, the director now directly owns 11,224 shares in the company, valued at approximately $2,686,576.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 8,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 1st. The stock was sold at an average price of $250.06, for a total transaction of $2,000,480.00. Following the transaction, the executive vice president now directly owns 217 shares of the company’s stock, valued at $54,263.02. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds have recently made changes to their positions in the business. MADDEN SECURITIES Corp bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. Bogart Wealth LLC grew its stake in shares of Intuitive Surgical by 70.1% in the third quarter. Bogart Wealth LLC now owns 148 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 61 shares in the last quarter. Larson Financial Group LLC grew its stake in shares of Intuitive Surgical by 196.1% in the second quarter. Larson Financial Group LLC now owns 151 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 100 shares in the last quarter. Evermay Wealth Management LLC grew its stake in shares of Intuitive Surgical by 103.4% in the fourth quarter. Evermay Wealth Management LLC now owns 118 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 60 shares in the last quarter. Finally, MV Capital Management Inc. grew its stake in shares of Intuitive Surgical by 138.9% in the second quarter. MV Capital Management Inc. now owns 172 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 100 shares in the last quarter. 81.96% of the stock is owned by institutional investors.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.